carlisle medical
Refill Requests shipment tracking contact carlisle medical
Knowledge Center
Industrial related news
Launch of Hysingla ER
Released: 11/20/2014
By: Carl Richie, Pharmacy Manager

The Federal Drug Administration (FDA) has approved the release of Hysingla ER, the first hard-to-abuse version of hydrocodone. Hysingla ER is an extended release opioid used to treat severe pain and should not be used for as-needed pain relief. The Hysingla ER tablet is labeled as having “abuse-deterrent properties”, which are expected to reduce, but not totally prevent, abuse of the drug when chewed and then taken orally, or crushed and snorted or injected.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at

Company News
Generic Releases
Industry Related News
Industry Related Links
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer